Results 231 to 240 of about 114,789,047 (289)

Iatrogenic Blepharoptosis: Multimodal Management and Treatment Technique With Botulinum Toxin Type A. [PDF]

Dermatol Res Pract
Jaime Alberto RP, Paola Andrea MA, Maria Paulina UP, Luisa LB.   +3 more
europepmc   +1 more source

Clinical and early biochemical responses to botulinum toxin type-A in refractory masticatory myofascial pain: a pilot single-arm study. [PDF]

BMC Oral Health
Meral SE, Buruş A, Karahan S, Bayrakçı N, Bayazıt Y.   +4 more
europepmc   +1 more source

Combination Therapy with Oral Doxycycline and Intradermal Botulinum Toxin Type A for Moderate-to-Severe Rosacea: A Randomized Controlled Trial. [PDF]

Indian J Dermatol
Nguyen TT, Le DH, Vu HT, Vu LH, Vu MN, Pham PTM.   +5 more
europepmc   +1 more source

Efficacy of botulinum toxin type A administration within the current therapeutic algorithm for chronic anal fissure: study protocol for the prospective multicentre observational study FISURBOT-GECO6. [PDF]

Tech Coloproctol
Ortega-Torrecilla N, Arredondo J, Marinello F, Reyes-Diaz ML, Cerdán C, Cano-Valderrama O, Fernández T, Cristóbal L, Calderón T, Martín-Pérez B.   +9 more
europepmc   +1 more source

Botulinum Toxin Type A Injection Into the Medial Gastrocnemius for Refractory Plantar Fasciitis: A Case Series. [PDF]

Cureus
Ventura Luís J, Martins E Pereira G, Cordeiro D, Freitas MM, Lorga S.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Clinical use of non-a botulinum toxins: Botulinum toxin type C and botulinum toxin type F

Neurotoxicity Research, 2006
Botulinum neurotoxin (BoNT) serotype A is commonly used in the treatment of focal dystonia, but some patients are primarily or become secondarily resistant to it. Consequently, other serotypes have to be used when immuno-resistance is proven. In the literature, patients with focal dystonia have been treated with BoNT serotype F with clinical benefit ...
ELEOPRA R, TUGNOLI V, QUATRALE R, ROSSETTO, ORNELLA, MONTECUCCO, CESARE, DRESSLER D.   +5 more
openaire   +3 more sources

Complications of Botulinum Toxin Type A

Facial Plastic Surgery Clinics of North America, 2007
Introduced over 30 years ago for the treatment of strabismus and blepharospasm, botulinum toxin type A (BTX-A) now has established uses for various therapeutic and cosmetic purposes. Although remarkably safe and effective, BTX-A is a potent toxin. Complications can occur, particularly when used by the inexperienced injectors.
Jean, Carruthers, Alastair, Carruthers
openaire   +2 more sources

Neurophysiological effects of botulinum toxin type a

Neurotoxicity Research, 2006
Botulinum toxin type A (BoNT-A) acts peripherally by inhibiting acetylcholine release from the presynaptic neuromuscular terminals, thus weakening muscle contraction, and its clinical benefit depends primarily on the toxin's peripheral action. In addition to acting directly at the neuromuscular junction, the toxin alters sensory inputs to the central ...
ABBRUZZESE, GIOVANNI, BERARDELLI A.
openaire   +3 more sources

Botulinum toxin type A for facial wrinkles

Cochrane Database of Systematic Reviews, 2021
Botulinum toxin type A (BontA) is the most frequent treatment for facial wrinkles, but its effectiveness and safety have not previously been assessed in a Cochrane Review.To assess the effects of all commercially available botulinum toxin type A products for the treatment of any type of facial wrinkles.We searched the following databases up to May 2020:
Cristina Pires, Camargo, Jun, Xia, Caroline S, Costa, Rolf, Gemperli, Maria Dc, Tatini, Max K, Bulsara, Rachel, Riera   +6 more
openaire   +2 more sources

Clinical use of non-a botulinum toxins: botulinum toxin type B

Neurotoxicity Research, 2006
Botulinum neurotoxin type B (BT, BT-B) has been used as NeuroBloc/MyoBloc since 1999 for treatment of cervical dystonia, hyperhidrosis, spastic conditions, cerebral palsy, hemifacial spasm, bladder dysfunction, spasmodic dysphonia, sialorrhoea, anal fissures, piriformis syndrome, various pain conditions and cosmetic applications.
D, Dressler, R, Eleopra
openaire   +2 more sources